Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development

Molecular Cell

Volumn 4, Issue 3, 1999, Pages 403-414

  Gerety, Sebastian S ^a   Wang, Hai U ^a   Chen, Zhou Feng ^a   Anderson, David J ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; MEMBRANE RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTERY; ARTICLE; CONTROLLED STUDY; EMBRYO; MOUSE; NONHUMAN; PHENOTYPE; PRECURSOR; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VEIN;

ANIMALIA; MUS MUSCULUS;

EID: 0033197535     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80342-1     Document Type: Article

References (42)

1. Adams, R., Wilkinson, G.A., Weiss, C., Diella, F., Gale, N.W., Deutsch, U., Risau, W., and Klein, R. (1999). Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/ venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13, 295-306.
2. Benjamin, L.E., Hemo, I., and Keshet, E. (1998). A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591-1598.
3. Bennett, B.D., Zeigler, F.C., Gu, Q., Fendly, B., Goddard, A.D., Gillett, N., and Matthews, W. (1995). Molecular cloning of a ligand for the Eph-related receptor protein tyrosine kinase Htk. Proc. Natl. Acad. Sci. USA 92, 1866-1870.
4. Bergemann, A.D., Cheng, H.J., Brambilla, R., Klein, R., and Flanagan, J.G. (1995). ELF-2, a new member of the Eph ligand family, is segmentally expressed in mouse embryos in the region of the hindbrain and newly forming somites. Mol. Cell. Biol. 15, 4921-4929.
5. Brambilla, R., Schnapp, A., Casagranda, F., Labrador, J.P., Bergemann, A.D., Flanagan, J.G., Pasquale, E.B., and Klein, R. (1995). Membrane-bound LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases. EMBO J. 14, 3116-3126.
6. Bruckner, K., Pasquale, E.B., and Klein, R. (1997). Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science 275, 1640-1643.
7. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
8. Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., Jain, V., Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C., and Yancopoulos, G.D. (1996). Isolation of Angiopoietin-1, a ligand for the Tie-2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169.
9. Drescher, U., Kremoser, C., Handwerker, C., Loschinger, J., Noda, M., and Bonhoeffer, F. (1995). In vitro guidance of retinal ganglion cell axons by RAGS, a 25kDa tectal protein related to ligands for Eph receptor tyrosine kinases. Cell 82, 359-370.
10. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell-Braxton, L., Hillan, K.J., and Moore, M.W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
11. Folkman, J. (1998a). Antiangiogenic gene therapy. Proc. Natl. Acad. Sci. USA 95, 9064-9066.
12. Folkman, J. (1998b). Angiogenic therapy of the human heart. Circulation 97, 628-629.
13. Folkman, J., and D'Amore, P.A. (1996). Blood vessel formation: What is its molecular basis? Cell 87, 1153-1155.
14. Fong, G.-H., Rossant, J., Gertsenstein, M., and Breitman, M.L. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.
15. Gale, N.W., and Yancopoulos, G.D. (1999). Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13, 1055-1066.
16. Gale, N.W., Holland, S.J., Valenzuela, D.M., Flenniken, A., Pan, L., Ryan, T.E., Henkemeyer, M., Strebhard, K., Hirai, H., Wilkinson, D.G., et al. (1996). Eph receptors and ligands comprise two major specificity subclasses, and are reciprocally compartmentalized during embryogenesis. Neuron 17, 9-19.
17. Goldman, C.K., Kendall, R.L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G.Y., Siegal, G.P., Mao, X., Bett, A.J., Huckle, W.R., et al. (1998). Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Natl. Acad. Sci. USA 95, 8795-8800.
18. Hanahan, D. (1997). Signaling vascular morphogenesis and maintenance. Science 277, 48-50.
19. Henkemeyer, M., Orioli, D., Henderson, J.T., Saxton, T.M., Roder, J., Pawson, T., and Klein, R. (1996). Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 86, 35-46.
20. Hirschi, K.K., Rohovsky, S.A., and D'Amore, P.A. (1998). PDGF, TGF β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141, 805-814.
21. Holland, S.J., Gale, N.W., Mbamalu, G., Yancopoulos, G.D., Henkemeyer, M., and Pawson, T. (1996). Bidirectional signaling through the Eph-family receptor nuk and its membrance ligands. Nature 383, 722-725.
22. Krull, C.E., Lansford, R., Gale, N.W., Collazo, A., Marcelle, C., Yancopoulos, G.D., Fraser, S.E., and Bronner-Fraser, M. (1997). Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. Curr. Biol. 7, 571-580.
23. Lin, P., Buxton, J.A., Acheeson, A., Radziejewski, C., Maisonpierre, P.C., Yancopoulos, G.D., Channon, K.M., Hale, L.R., Dewhirst, M.W., George, S.E., and Peters, K.G. (1998). Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc. Natl. Acad. Sci. USA 95, 8829-8834.
24. Ma, Q., Chen, Z.F., Barrantes, I.B., de la Pompa, J.L., and Anderson, D.J. (1998). Neurogenin 1 is essential for the determination of neuronal precursors for proximal cranial sensory ganglia. Neuron 20, 469-482.
25. Mellitzer, G., Xu, Q., and Wilkinson, D.G. (1999). Eph receptors and ephrins restrict cell intermingling and communication. Nature 400, 77-81.
26. Mombaerts, P., Wang, F., Dulac, C., Chao, S.K., Nemes, A., Mendelsohn, M., Edmondson, J., and Axel, R. (1996). Visualizing an olfactory sensory map. Cell 87, 675-686.
27. Nakamoto, M., Cheng, H.-J., Friedman, G.C., McLaughlin, T., Hansen, M.J., Yoon, C.H., O'Leary, D.D.M., and Flanagan, J.G. (1996). Topographically specific effects of ELF-1 on retinal axon guidance in vitro and retinal axon mapping in vivo. Cell 86, 755-766.
28. Pandey, A., Shao, H., Marks, R.M., Polverini, P.J., and Dixit, V.M. (1995). Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-a-induced angiogenesis. Science 268, 567-569.
29. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
30. Risau, W., and Flamme, I. (1995). Vasculogenesis. Annu. Rev. Cell. Dev. Biol. 11, 73-91.
31. Sakano, S., Serizawa, R., Inada, T., Iwama, A., Itoh, A., Kato, C., Shimizu, Y., Shinkai, F., Shimizu, R., Kondo, S., et al. (1996). Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells. Oncogene 13, 813-822.
32. Sato, T.N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., and Qin, T. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.
33. Schumacher, B., Pecher, P., von Specht, B.U., and Stegmann, T. (1998). Induction of neoangiogenesis in ischemic myocardium by human growth factors. Circulation 97, 645-650.
34. Shalaby, F., Rossant, J., Tamaguchi, T.P., Gertsenstein, M., Wu, X.-F., Breitman, M.L., and Schuh, A.C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
35. Smith, A., Robinson, V., Patel, K., and Wilkinson, D.G. (1997). The EphA4 and EphB1 receptor tyrosine kinases and EphrinB2 ligand regulate targeted migration of branchial neural crest cells. Curr. Biol. 7, 561-570.
36. Stein, E., Lane, A.A., Cerretti, D.P., Schoecklmann, H.O., Schroff, A.D., Van Etten, R.L., and Daniel, T.O. (1998). Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 12, 667-678.
37. Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N., and Yancopoulos, G.D. (1996). Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
38. Turner, D.L., and Weintraub, H. (1994). Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev. 8, 1434-1447.
39. Tybulewicz, V.L.J., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
40. Wang, H.U., and Anderson, D.J. (1997). Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron 18, 383-396.
41. Wang, H.U., Chen, Z.-F., and Anderson, D.J. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor EphB4. Cell 93, 741-753.
42. Xu, Q., Mellitzer, G., Robinson, V., and Wilkinson, D.G. (1999). In vivo cell sorting in complementary segmental domains mediated by Eph receptors and ephrins. Nature 399, 267-2271.